Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ferrocene Homoallylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.